MBCOFMARVEL BIOSCIENCES CORP.

About MARVEL BIOSCIENCES CORP. (MBCOF)

MARVEL BIOSCIENCES CORP. (MBCOF) is a Biotechnology company headquartered in Calgary, AB, Canada whose shares trade over-the-counter on the OTCQB tier.

Marvel Biosciences Corp is a life sciences company focused on the discovery and the development of a synthetic derivative compound of a known proven drug. It has developed several new patented and patentable chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, ADHD and addiction), cancer, and application to the non-neurological disease of non-alcoholic steatohepatitis liver fibrosis.

Products and services

The Company is a pre-clinical stage pharmaceutical development biotechnology company that utilizes a "drug redevelopment" approach to drug development. Marvel develops new synthetic chemical derivatives of an original approved drug for new disease indication. The Company has currently developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis.

MBCOF key facts

Ticker symbol

MBCOF

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

Calgary, AB, Canada

Country of incorporation

CA

Year of incorporation

2021

Employees

1

Estimated market cap

$3.85M (as of Apr 11, 2025)

Shares outstanding

44,803,731

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

7/31

Latest filing

Interim Financial Report (Oct 31, 2024)

MARVEL BIOSCIENCES CORP. leadership

• J. Roderick Matheson — CEO
• Harry Nijjar — CFO
• Mark Stephen Williams — Chief Scientific Officer
• Jacqueline Groot — Company Secretary

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with M